TY - JOUR
T1 - Kidney allografts and remaining contralateral donor kidneys before and after transplantation
T2 - Assessment by quantitative 99mTc-DMSA SPECT
AU - Even-Sapir, Einat
AU - Gutman, Mordechai
AU - Lerman, Hedva
AU - Kaplan, Eli
AU - Ravid, Anat
AU - Livshitz, Genady
AU - Nakache, Richard
PY - 2002
Y1 - 2002
N2 - We used 99mTc-dimercaptosuccinic acid (DMSA) quantitative SPECT (QDMSA) to assess the function of kidneys before harvesting and after transplantation as well as the function of remaining donor kidneys. Methods: Nineteen kidney donors underwent a baseline QDMSA study before nephrectomy. The allografts of these kidneys were studied in recipients at 1 wk, 1-2 mo, and 6-15 mo after transplantation. The kidneys remaining in 16 donors were studied at 1-2 mo and 6-15 mo after harvesting. The parameters obtained in each SPECT study included functional volume, concentration of 99mTc-DMSA per cubic centimeter of renal tissue, and total kidney uptake. Clinical evaluation and determination of serum creatinine levels took place at the same time as SPECT. Results: On the basis of the clinical evaluation, 14 grafts had normal function and 5 were impaired. The mean ± SD of kidney uptake values expressed as percentage of baseline values were 131% ± 30% in normal grafts versus 57% ± 5% in impaired grafts at 1 wk (P < 0.01), 173% ± 57% versus 65% ± 10% at 1-2 mo (P < 0.001), and 190% ± 50% versus 69% ± 14% at 6-15 mo after transplantation (P < 0.01). Uptake values in the donors' remaining kidneys were 159% ± 27% of baseline values at 1-2 mo and 164% ± 30% at 6-15 mo after nephrectomy. Allografts and remaining kidneys showed a similar increase in total kidney uptake as a result of an increase in both functional volume and concentration. Conclusion: QDMSA may be a noninvasive assessment tool in kidney transplantation from living donors.
AB - We used 99mTc-dimercaptosuccinic acid (DMSA) quantitative SPECT (QDMSA) to assess the function of kidneys before harvesting and after transplantation as well as the function of remaining donor kidneys. Methods: Nineteen kidney donors underwent a baseline QDMSA study before nephrectomy. The allografts of these kidneys were studied in recipients at 1 wk, 1-2 mo, and 6-15 mo after transplantation. The kidneys remaining in 16 donors were studied at 1-2 mo and 6-15 mo after harvesting. The parameters obtained in each SPECT study included functional volume, concentration of 99mTc-DMSA per cubic centimeter of renal tissue, and total kidney uptake. Clinical evaluation and determination of serum creatinine levels took place at the same time as SPECT. Results: On the basis of the clinical evaluation, 14 grafts had normal function and 5 were impaired. The mean ± SD of kidney uptake values expressed as percentage of baseline values were 131% ± 30% in normal grafts versus 57% ± 5% in impaired grafts at 1 wk (P < 0.01), 173% ± 57% versus 65% ± 10% at 1-2 mo (P < 0.001), and 190% ± 50% versus 69% ± 14% at 6-15 mo after transplantation (P < 0.01). Uptake values in the donors' remaining kidneys were 159% ± 27% of baseline values at 1-2 mo and 164% ± 30% at 6-15 mo after nephrectomy. Allografts and remaining kidneys showed a similar increase in total kidney uptake as a result of an increase in both functional volume and concentration. Conclusion: QDMSA may be a noninvasive assessment tool in kidney transplantation from living donors.
KW - SPECT
KW - Tc-dimercaptosuccinic acid
KW - Transplantation
UR - http://www.scopus.com/inward/record.url?scp=0036256881&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 11994518
AN - SCOPUS:0036256881
SN - 0161-5505
VL - 43
SP - 584
EP - 588
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 5
ER -